Mendelian Randomization Found No Genetic Link Between Cannabis Use Disorder and Cancer Risk
A Mendelian randomization study found no causal association between cannabis use disorder and any cancer type, while opioid use disorder was linked to bladder cancer, leukemia, and ovarian cancer risk.
Quick Facts
What This Study Found
No significant causal relationship was found between CUD and any cancer type (all P>0.05). OUD showed potential causal associations with bladder cancer (OR 1.040), acute myeloid leukemia (OR 0.931), and ovarian cancer (OR 0.937). Reverse MR found no evidence of cancers causing OUD.
Key Numbers
CUD: no significant association with any cancer (all P>0.05). OUD: bladder cancer OR 1.040 (P=0.029), AML OR 0.931 (P=0.005), ovarian cancer OR 0.937 (P=0.010). Data from FinnGen and UK Biobank GWAS.
How They Did This
Two-sample Mendelian randomization using GWAS summary statistics from FinnGen and UK Biobank. Inverse-variance weighted primary analysis with sensitivity analyses. Tested both CUD and OUD as exposures with multiple cancer types as outcomes.
Why This Research Matters
While observational studies have suggested links between cannabis use and cancer, this MR study uses genetic variants as instrumental variables to test causality, finding no support for a CUD-cancer connection.
The Bigger Picture
The null finding for CUD and cancer is reassuring but should be interpreted cautiously. MR studies depend on the strength and specificity of genetic instruments, which may be limited for CUD given current GWAS sample sizes.
What This Study Doesn't Tell Us
MR assumptions may not be fully met. CUD GWAS instruments may lack power. Predominantly European-ancestry populations. Cannot assess dose-response or specific cancer subtypes in detail. Adjusted P-values did not reach significance for OUD associations.
Questions This Raises
- ?Would larger CUD GWAS improve power to detect cancer associations?
- ?Does cannabis consumption method (smoking vs. edibles) differentially affect cancer risk?
Trust & Context
- Key Stat:
- Evidence Grade:
- MR design provides stronger causal inference than observational studies, but CUD instrument limitations and European-ancestry bias limit to moderate.
- Study Age:
- Uses current GWAS data from FinnGen and UK Biobank.
- Original Title:
- Decoding the genetic links between substance use disorder and cancer vulnerability.
- Published In:
- Psychopharmacology, 242(9), 2021-2033 (2025)
- Authors:
- Su, Xin, Mo, Xiaoyan, Kan, Jun, Yang, Fan, Zhang, Bei, Huang, Yuanyuan
- Database ID:
- RTHC-07740
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Does cannabis cause cancer?
This genetic study found no causal link between cannabis use disorder and any cancer type. However, this does not address whether cannabis smoke itself (as a route of exposure) might increase cancer risk.
What is Mendelian randomization?
A method using genetic variants associated with an exposure (like CUD) as natural experiments to test whether the exposure causes an outcome (like cancer), providing stronger evidence than typical observational studies.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-07740APA
Su, Xin; Mo, Xiaoyan; Kan, Jun; Yang, Fan; Zhang, Bei; Huang, Yuanyuan. (2025). Decoding the genetic links between substance use disorder and cancer vulnerability.. Psychopharmacology, 242(9), 2021-2033. https://doi.org/10.1007/s00213-025-06781-3
MLA
Su, Xin, et al. "Decoding the genetic links between substance use disorder and cancer vulnerability.." Psychopharmacology, 2025. https://doi.org/10.1007/s00213-025-06781-3
RethinkTHC
RethinkTHC Research Database. "Decoding the genetic links between substance use disorder an..." RTHC-07740. Retrieved from https://rethinkthc.com/research/su-2025-decoding-the-genetic-links
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.